MedPath

Does Mirabegron Have a Positive Impact on Sexual Function in Females With Overactive Bladder

Conditions
Females With Overactive Bladder Symptoms, Urgency & Urge Incontinence
Registration Number
NCT04511273
Lead Sponsor
Kasr El Aini Hospital
Brief Summary

80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms

Detailed Description

80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • any female with overactive bladder symptoms, urgency and urgency incontinence
Exclusion Criteria
  • neurologic abnormalities
  • Weak bladder contractility
  • Diabetics

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sexual function evaluation after 6 months6 months

Sexual function evaluation using female sexual function index FSFI

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath